Table 3.
Factors associated with HCs for elderly patients with liver cancer in their LML
| Covariates | Estimate | O.R. | 95% C.I. | p value |
|---|---|---|---|---|
| ICU | 2.59 | 13.34 | 7.69–23.14 | <0.001 |
| Ventilator | 1.24 | 3.46 | 2.04–5.87 | <0.001 |
| Anti-cancer treatmentsa | 1.00 | 2.72 | 1.60–4.62 | <0.001 |
| Admission days | 0.22 | 1.25 | 1.21–1.30 | <0.001 |
| Admission times | −0.85 | 0.43 | 0.27–0.68 | <0.001 |
| CKD | 1.07 | 2.92 | 1.44–5.93 | 0.003 |
| EVB | 0.81 | 2.26 | 1.17–4.36 | 0.015 |
| Opioids use | 0.61 | 1.85 | 1.17–2.91 | 0.009 |
| Ascites | −1.08 | 0.34 | 0.20–0.59 | <0.001 |
| Hypertension | −0.52 | 0.59 | 0.36–0.99 | 0.046 |
| Intercept | −6.92 | <0.001 |
In this final model, 2049 cases (96.61%) were enrolled for analysis after excluding those (n = 72, 3.39%) with missing data
Abbreviations: ICU intensive care unit, CKD chronic kidney disease, EVB esophageal varices with bleeding
aAnti-cancer treatments included TACE, Radiotherapy, Chemotherapy, HAIC, PEI, and RFA